ANSLY:OTC-Ansell Limited (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC

Last Closing Price

USD 103.84

Change

0.00 (0.00)%

Market Cap

USD 3.45B

Volume

653.00

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Ansell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by healthcare, life sciences, and industrial workers for a range of customers, including hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and pharmaceutical companies. The Industrial segment manufactures and markets high-performance hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.

Company Website : http://www.ansell.com

Address : 678 Victoria Street, Richmond, VIC, Australia, 3121

Employees : 13,513

Fiscal Year End : June

Currency: USD

Country : USA

Technical Indicators

Beta : 0.90

52 Week High : 116.74

52 Week Low : 46.56

200 Day Moving Average : 94.23

50 Day Moving Average : 109.83

Shares Held by Institutions : 0.06%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-26 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ESLOY EssilorLuxottica Société ano..

N/A

 USD61.52B 46.33 26.76
ESLOF EssilorLuxottica Société ano..

N/A

 USD59.05B 46.12 26.76
HOCPY HOYA Corporation

N/A

 USD48.21B 44.16 0.24
HOCPF HOYA Corporation

N/A

 USD47.01B 44.45 0.24
SDMHF Sartorius Stedim Biotech S.A

N/A

 USD30.83B 93.55 63.41
TRUMF Terumo Corporation

N/A

 USD30.65B 44.33 0.33
CLPBY Coloplast A/S

N/A

 USD30.59B 46.46 4.87
CLPBF Coloplast A/S

N/A

 USD30.52B 47.92 5.06
TRUMY Terumo Corporation

N/A

 USD30.14B 44.51 0.32
RSMDF ResMed Inc

N/A

 USD29.93B 37.77 30.67

ETFs Containing ANSLY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.53% N/A N/A N/A N/A
Dividend Return 1.37% N/A N/A N/A N/A
Total Return 26.90% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 27.82% N/A N/A N/A N/A
Dividend Return 1.39% N/A N/A N/A N/A
Total Return 29.21% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 87.07% N/A N/A N/A N/A
Dividend Return 13.04% N/A N/A N/A N/A
Total Return 100.10% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.13% N/A N/A 61% D-
Dividend Return 2.09% N/A N/A 58% F
Total Return 12.22% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 16.74% N/A N/A 79% C+
Risk Adjusted Return 72.96% N/A N/A 94% A
Market Capitalization 3.45B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 21.34 N/A N/A N/A N/A
Price/Book Ratio 2.36 N/A N/A N/A N/A
Price / Cash Flow Ratio 11.85 N/A N/A N/A N/A
EV/EBITDA 10.96 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 11.38% N/A N/A N/A N/A
Return on Invested Capital 10.00% N/A N/A N/A N/A
Return on Assets 5.69% N/A N/A N/A N/A
Debt to Equity Ratio 33.77% N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.90 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike